KS

Katalyst Securities

North America, New York, United States, New York

Description

Katalyst Securities is an independent brokerage firm specializing in private equity investments.

Investor Profile

Katalyst Securities has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Post Ipo Debt, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Life Science.

Stage Focus

  • Series Unknown (33%)
  • Post Ipo Debt (33%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Life Science
  • Therapeutics
  • Location Based Services
  • Media And Entertainment
  • Music
  • Fitness
  • Health Care
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Katalyst Securities frequently co-invest with?

IV
North America, New York, United States, New York
Co-Investments: 1
Co-Investments: 1
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 1
Tempus
North America, Illinois, United States, Chicago
Co-Investments: 1
Kirenaga Partners
North America, New York, United States, Bronxville
Co-Investments: 1

Which angels does Katalyst Securities often collaborate with?

PG
North America, Illinois, United States, Chicago
Shared Deals: 1
David R. Walt
North America, Massachusetts, United States, Boston
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 1
Shared Deals: 1
MT
North America, New York, United States, New York
Shared Deals: 1
EL
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by Katalyst Securities?

Violet Defense

Orlando, Florida, United States

Violet Defense Group is dedicated to protecting the world from germs by bringing clinical-level UV disinfection to everyday spaces.

FitnessHealth CareManufacturingMedicalMedical Device
Series BNov 2, 2021
Amount Raised: $20,000,000
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series UnknownSep 27, 2017
Amount Raised: $20,000,000
CÜR Media

South Glastonbury, Connecticut, United States

CUR Media is a mobile application that enables its users to create online profiles to share music with their photos and videos.

Location Based ServicesMedia and EntertainmentMusic
Post Ipo DebtApr 13, 2016
Amount Raised: $2,060,000